Articles for tag: Investing, Stocks, US Markets

January 9, 2025

Ron Finklestien

Navigating LLY’s 14% Decline: Investment Strategies for the Coming Months

Understanding Eli Lilly’s Recent Stock Performance: What Does the Future Hold? Eli Lilly and Company (LLY) has seen its shares decrease by 13.5% over the past three months. Despite strong demand for its tirzepatide products, Mounjaro and Zepbound, sales have been affected by inventory challenges in the third quarter. This decline occurred after a robust performance in the first half of the year and contributed to the overall drop in the company’s stock price following its third-quarter results. The drug and biotech industry as a whole has struggled recently, particularly after the announcement of Robert F. Kennedy Jr. as the

December 7, 2024

Ron Finklestien

“Oklo’s Stock Rises 90% in 2023: Should Investors Consider Buying Now?”

Oklo Inc. Soars 90% Amid Clean Energy Demand: Investing Insights Oklo Inc.’s OKLO shares have soared an impressive 90.1% this year, significantly outperforming the Zacks Alternative-Energy industry, which gained 60.8%, and the broader Zacks Oils-Energy sector, which saw only a 6.8% rise. Additionally, OKLO shares surpassed the S&P 500’s increase of 27.7% during the same time frame. The uptick in interest for clean energy sources is driving Oklo’s growth, as the company has formed new partnerships and taken initiatives that showcase its commitment to supplying reliable, large-scale clean energy solutions. Several companies in this sector have also enjoyed remarkable success.

November 29, 2024

Ron Finklestien

American Eagle Prepares for Q3 Earnings Release: Key Insights and Predictions

American Eagle Outfitters Set to Report Modest Growth in Q3 Fiscal 2024 American Eagle Outfitters, Inc. (AEO) is anticipated to showcase revenue growth when it releases its third-quarter fiscal 2024 results on December 4. Analysts expect revenues to reach $1.30 billion, reflecting a 0.3% increase compared to the previous year. The estimated earnings stand at 46 cents per share, demonstrating a drop of 6.1% from the last year’s quarter. Over the last month, the earnings consensus has adjusted downward by a penny. In the most recent quarter, American Eagle exceeded earnings expectations by 2.6%. On average, it has delivered a

November 21, 2024

Ron Finklestien

Sociedad Quimica Reports Below-Expected Earnings and Revenues for Q3

Sociedad Quimica y Minera S.A. Posts Disappointing Q3 Earnings Key Insights from SQM’s Third Quarter SQM earnings per share in Q3 was 46 cents, far below the Zacks estimate of 64 cents. SQM shares have lost 23.6% in the past year, compared to a 13.1% decline in the Fertilizers industry. Register now to see our 7 Best Stocks for the Next 30 Days report – free today! Sociedad Quimica y Minera de Chile S.A. (SQM) reported a profit of $131.4 million, or 46 cents per share, in the third quarter of 2024. This marks a significant decrease from the $479.4

October 31, 2024

Ron Finklestien

Emerson Electric Prepares for Q4 Earnings Announcement: Will They Surpass Expectations?

Emerson Electric Co. Poised for Growth Ahead of Q4 Fiscal 2024 Earnings Report Emerson Electric Co. EMR is set to announce its fourth-quarter fiscal 2024 results (ending September 30, 2024) on November 5, just before the market opens. Analysts expect revenues to reach $4.58 billion, reflecting a robust growth of 11.9% compared to the same quarter last year. Stay informed on all quarterly releases with Zacks’ Earnings Calendar. The expected earnings per share (EPS) stands at $1.47, consistent over the past 60 days, indicating a 14% increase year-over-year. In the previous quarter, the company’s earnings exceeded the Zacks Consensus Estimate

October 28, 2024

Ron Finklestien

Barnes Group Reports Q3 Earnings Below Expectations Despite Year-over-Year Sales Growth

Barnes Group Inc. Reports Dismal Third-Quarter Earnings Amid Mixed Sales Performance Barnes Group Inc. reported adjusted earnings of 9 cents per share for the third quarter of 2024, falling short of the Zacks Consensus Estimate of 39 cents. This marks a significant decline of 52% compared to the same quarter last year. Keep track of all quarterly updates: See Zacks Earnings Calendar. Sales Overview: A Tale of Two Segments Total sales reached $388 million, exceeding the Zacks Consensus Estimate of $373 million. This represents a year-over-year increase of 7%, with organic sales growth recorded at 4%. Barnes Group’s sales are

September 23, 2024

Ron Finklestien

What’s Driving Unilever Stock Higher?

Unilever stock (NYSE: UL) has gained 32% in value since early January 2022 – jumping from levels of $49 then to $64 now – vs. an increase of about 18% for the S&P 500 over this period. This can primarily be attributed to a 12% rise in the stock’s P/E ratio from 22x in 2021 to 24.5x now. Furthermore, the company’s net income grew 15% from $5.8 billion to $6.6 billion over the same period. Profit growth was driven by higher sales and margin expansion. Investors have rewarded UL stock thanks to the uptick in its profitability. Our dashboard on

September 11, 2024

Ron Finklestien

Seizing the Opportunity: Oracle’s Stock Soars Post-Earnings

A Glimpse into Oracle’s Q1 Triumph Oracle (ORCL) investors have hit the jackpot today with a whopping +10% surge in stock prices, following the company’s exceptional performance in its fiscal first quarter. Cloud infrastructure revenue, bolstered by cutting-edge artificial intelligence applications in collaboration with Nvidia (NVDA), spearheaded Oracle’s phenomenal Q1 results. Unveiling Revenue Guidance & Growth Projections In terms of figures, Oracle’s Q1 sales exhibited a 7% increase from the previous year, totaling $13.3 billion and surpassing estimates by a whisker. Earnings per share stood strong at $1.39, outperforming expectations by 5% and marking a significant 17% leap from Q1

September 9, 2024

Ron Finklestien

Investing in Dole and Pilgrim’s Pride: Savoring Stability Amid Market Chaos

September has a reputation for stirring up turbulence in the stock market, but amidst the chaos, Dole and Pilgrim’s Pride emerge as beacons of stability for investors seeking a safe haven in the stormy seas of volatility. Two Food Giants Weathering the Storm As market volatility heightens, Dole and Pilgrim’s Pride offer a glimmer of hope for investors seeking refuge. These two stalwarts in the consumer food industry, holding coveted spots on the Zacks Rank #1 (Strong Buy) list, are proving their mettle amidst the market mayhem. Dole: Nurturing Health, Growing Prosperity As a leading purveyor of fresh fruits including

May 30, 2024

Ron Finklestien

How Are CVS Health’s Profit Margins Trending?

CVS Health (NYSE: CVS) saw its net income expand by $4.2 billion or 101% y-o-y to $8.3 billion in 2023. This can primarily be attributed to the opioid litigation charges included in the 2022 results. In this note, we discuss CVS’ margin profile along with its stock performance, over the last three years. Firstly, let us look at CVS’ stock performance. CVS stock has faced a notable decline of 20% from levels of $70 in early January 2021 to around $55 now, vs. an increase of about 40% for the S&P 500 over this roughly three-year period. However, the decrease